Nephro Care India Q2 Results FY27: Revenue Jumps 51.43% to Rs 33.30 Cr, PAT Rs 2.76 Cr

Nephro Care India Ltd (NEPHROCARE) Q2 Results FY27 announced on 12 November 2026, covering the company's financial performance for the July to September quarter. Revenue stood at Rs 33.30 Cr and net profit at Rs 2.76 Cr. Investors following Nephro Care India Q2 Results FY27 can find the results date, the revenue figure and the PAT figure together on Univest, with the results date of 12 November 2026 as the reference point for every comparison.

This Nephro Care India Q2 Results analysis covers the financial highlights, the business factors behind the quarter, the outlook and the risks. The results analysis uses only the figures filed with the exchanges, NSE and BSE, and it begins with the Financial Highlights below. Univest Screener users can then match these numbers against other listed companies.

Click Here – Get Free Investment Predictions

Nephro Care India Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 33.3 Cr	Rs 21.99 Cr	+51.43% YoY
Net Profit (PAT)	Rs 2.76 Cr	Rs 2.59 Cr	+6.56% YoY

Source: company filing for Nephro Care India Q2 Results FY27, 12 November 2026. Figures in Rs Crore.

Key Takeaways from Nephro Care India Q2 Results: What Stands Out

• Revenue: Rs 33.30 Cr in the quarter, up 51.43% year on year from Rs 21.99 Cr, which is the headline figure in Nephro Care India Q2 Results FY27.
• Net profit: Rs 2.76 Cr, up 6.56% from Rs 2.59 Cr, a YoY growth rate well below the revenue rise.
• Net profit margin: 8.3% in the latest quarter against 11.8% in the comparison quarter, based on the reported figures.
• Revenue trend: revenue has risen in each of the last 4 quarters, so the latest figure sits inside a rising series.
• Debt: the company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26.
• Next step: the performance analysis below shows how revenue and net profit fit together this quarter.

Nephro Care India Q2 Results FY27: Performance Analysis

Nephro Care India Q2 Results FY27 show revenue of Rs 33.30 Cr, up 51.43% from Rs 21.99 Cr a year earlier, and net profit of Rs 2.76 Cr, up 6.56% from Rs 2.59 Cr. Both lines grew YoY, and revenue grew much faster than net profit. This results analysis rests on the figures filed on 12 November 2026.

The revenue gain of 51.43% sits against a net profit gain of 6.56%, and net profit margin stood at 8.3% against 11.8% a year earlier. Net profit therefore took a smaller share of revenue in the latest quarterly results. Nephro Care India Q2 Results is best read with both movements in view.

Investors tracking Nephro Care India Q2 Results FY27 will want to see whether the YoY growth in revenue carries into net profit in later disclosures, since net profit has moved between Rs 0.42 Cr and Rs 2.76 Cr over the last 5 quarters. That is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue growth – The results analysis points first to revenue growth of 51.4% year on year to Rs 33.30 Cr, the central figure in Nephro Care India Q2 Results FY27. Revenue has also risen in each of the last 4 quarters, which places the latest quarter inside a rising series.

Net profit growth – Net profit rose 6.6% year on year to Rs 2.76 Cr in the latest quarterly results, against Rs 2.59 Cr in the comparison quarter. Net profit growth was smaller than revenue growth over the same period.

Balance sheet – The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. This full-year figure describes the balance sheet position that stands behind the revenue and net profit reported for the quarter.

FY27 Outlook After Nephro Care India Q2 Results

FY27 full-year performance will depend on the quarters still to be reported. This results analysis treats the July to September 2026 quarter as one input, with revenue of Rs 33.30 Cr and net profit of Rs 2.76 Cr, and does not extend it into any forecast. Later disclosures after the results date will show how the figures settle.

Nephro Care India Q2 Results FY27 set the base for comparison as the next quarters arrive. Investors can compare each new net profit figure against Rs 2.76 Cr and each revenue figure against Rs 33.30 Cr. The key risks that could move those numbers are covered next.

Key Risks to Watch After Nephro Care India Q2 Results FY27

Narrower Net Profit Margin

Net profit margin narrowed to 8.3% from 11.8% in the comparison quarter. After Nephro Care India Q2 Results FY27, investors can watch whether later quarters show the YoY growth in revenue reaching net profit.

Return Ratios

Return on equity was low at 5.93% in FY26, and return on capital employed was modest at 8.44% in FY26. Both are disclosed risks, and the next annual figures will show whether the ratios move.

Net Profit Volatility

Quarterly net profit has been volatile, ranging from Rs 0.42 Cr to Rs 2.76 Cr over the last 5 quarters. A single quarter's net profit figure therefore does not settle the next quarter's number.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Nephro Care India Q2 Results FY27 show revenue of Rs 33.30 Cr and net profit of Rs 2.76 Cr, both higher year on year. The Rs 2.76 Cr net profit is the figure to track in coming disclosures. These quarterly results gain more meaning when Nephro Care India Q2 Results is read alongside later filings. Investors should consult a SEBI-registered advisor before acting on this information.

Frequently Asked Questions on Nephro Care India Q2 Results FY27

What are Nephro Care India Q2 Results FY27?

Ans. Nephro Care India Q2 Results FY27 are the quarterly results declared on 12 November 2026 for July to September 2026, showing revenue of Rs 33.30 Cr and net profit of Rs 2.76 Cr, as summarised in the Quick Answer.

What is the results date for Nephro Care India Q2 Results FY27?

Ans. Nephro Care India declared its quarterly results on 12 November 2026, which is the results date for the July to September 2026 quarter. This date opens the article alongside the headline revenue and net profit figures.

What revenue was reported in Nephro Care India Q2 Results FY27?

Ans. Nephro Care India reported revenue of Rs 33.30 Cr in the quarter, compared with Rs 21.99 Cr a year earlier. This figure appears in the Financial Highlights table and is analysed in the Performance Analysis section.

What net profit was reported in Nephro Care India Q2 Results FY27?

Ans. Nephro Care India reported net profit of Rs 2.76 Cr, against Rs 2.59 Cr in the same quarter last year, which means net profit grew 6.56% YoY, as shown in the Key Takeaways section.

How much YoY growth did revenue show in Nephro Care India Q2 Results FY27?

Ans. Nephro Care India Q2 Results FY27 show revenue up 51.43% YoY, rising from Rs 21.99 Cr to Rs 33.30 Cr. Alongside this, net profit grew more slowly at 6.56%, as covered in the Performance Analysis section.

Did net profit rise or fall in Nephro Care India Q2 Results?

Ans. Net profit rose in Nephro Care India Q2 Results, reaching Rs 2.76 Cr from Rs 2.59 Cr a year earlier. This rise of 6.56% YoY is the main net profit figure in the Key Takeaways section.

What was the net profit margin in Nephro Care India Q2 Results FY27?

Ans. Nephro Care India posted a net profit margin of 8.3% against 11.8% in the comparison quarter. This follows from the revenue and net profit figures, which the Key Risks section explains as a narrower margin.

Has revenue risen in recent quarters in Nephro Care India Q2 Results?

Ans. Revenue has risen in each of the last 4 quarters, with the latest quarter at Rs 33.30 Cr. This pattern is described in the Key Business Factors section, so it adds context to the YoY growth figure.

What business factors shaped Nephro Care India Q2 Results FY27?

Ans. The disclosed factors are revenue growth of 51.4% YoY, net profit growth of 6.6% YoY and an almost debt free balance sheet with a debt-to-assets ratio of 0.00 in FY26. Each one is explained in the Key Business Factors section.

What are the key risks after Nephro Care India Q2 Results FY27?

Ans. The disclosed risks are a narrower margin of 8.3% against 11.8%, return on equity of 5.93% and return on capital employed of 8.44% in FY26, and volatile net profit. The Key Risks section covers each one.

What is the outlook after Nephro Care India Q2 Results?

Ans. FY27 full-year results will depend on the quarters still to be reported. Compared with that, the July to September 2026 quarter is one data point, as the FY27 Outlook section explains.

Where can I find the complete Nephro Care India Q2 Results FY27 data?

Ans. The complete Nephro Care India Q2 Results FY27 data appears in the Financial Highlights table on this page, which lists revenue and net profit with YoY growth. The Univest Screener also lets investors compare these figures with other companies.